|
Commercial and development opportunities for big pharma, biotech,
investors and research organizations
North America’s largest commercial stem cells & regenerative medicine event
Including 45+ of the world’s most innovative & influential speakers over 3 content-packed days
Bringing together industry leaders from big pharma, biotechs, government & research organizations
Organogenesis, Tengion, Genzyme, NovoCell, Fate Therapeutics, Cellerant Therapeutics, CellSeed, Cellerix, Garnet BioTherapeutics, DARPA, FDA, CIRM, NIH, Pfizer, Roche, Baxter, Wake Forest Institute for Regenerative Medicine, The Harvard Stem Cell Institute & many more…
Addressing challenges & opportunities for commercialization of stem cells & regenerative medicine
Focus on regenerative medicine & stem cells for drug discovery & development
|
Key topics:
- Funding and partnership models
- Stem cells as tools in predicting drug toxicity
- Stems cells as tools in drug discovery - target identification & validation
- Effective utilizations of iSP cells
- Novel strategies for study of disease
- Commercialization challenges
- Regulatory updates & strategies to overcome regulatory hurdles
- Enhanced production & manufacturing systems
- Big pharma perspective on future commercialization of stem cell therapeutics
- The challenge of commercialization
- Cardiovascular stem cell therapeutics
- Skin, bone & hair stem cell therapeutics
» Request more information
» Register today
|
» Download the brochure
|
Meet, network and discover new strategies
|
Stem Cells USA & Regenerative Medicine Congress will explore the scientific and business aspect of this rapidly growing market. Industry experts will cover all the main topics - discovery & development of stem cells, potential applications, regulation and partnering for success. This is where global pharmaceutical companies, biotechs, academics and investors gather to discuss innovation, market opportunities and partnership models.
» Find out how you could benefit
» Reserve your seat now and save
|
|
